MXPA03001673A - Bacteria de acido lactico capaz de reducir una tendencia individual a desarrollar reacciones alergicas. - Google Patents
Bacteria de acido lactico capaz de reducir una tendencia individual a desarrollar reacciones alergicas.Info
- Publication number
- MXPA03001673A MXPA03001673A MXPA03001673A MXPA03001673A MXPA03001673A MX PA03001673 A MXPA03001673 A MX PA03001673A MX PA03001673 A MXPA03001673 A MX PA03001673A MX PA03001673 A MXPA03001673 A MX PA03001673A MX PA03001673 A MXPA03001673 A MX PA03001673A
- Authority
- MX
- Mexico
- Prior art keywords
- tendency
- individual
- lactic acid
- acid bacteria
- allergic reactions
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract 6
- 241000894006 Bacteria Species 0.000 title abstract 3
- 206010020751 Hypersensitivity Diseases 0.000 title abstract 3
- 235000014655 lactic acid Nutrition 0.000 title abstract 3
- 239000004310 lactic acid Substances 0.000 title abstract 3
- 244000005700 microbiome Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000003614 tolerogenic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1236—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using Leuconostoc, Pediococcus or Streptococcus sp. other than Streptococcus Thermophilus; Artificial sour buttermilk in general
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C2220/00—Biochemical treatment
- A23C2220/20—Treatment with microorganisms
- A23C2220/202—Genetic engineering of microorganisms used in dairy technology
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/151—Johnsonii
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/231—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Dairy Products (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00120867 | 2000-09-25 | ||
| PCT/EP2001/010956 WO2002024883A2 (en) | 2000-09-25 | 2001-09-21 | Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03001673A true MXPA03001673A (es) | 2003-06-09 |
Family
ID=8169939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03001673A MXPA03001673A (es) | 2000-09-25 | 2001-09-21 | Bacteria de acido lactico capaz de reducir una tendencia individual a desarrollar reacciones alergicas. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7498162B2 (es) |
| EP (1) | EP1379635A2 (es) |
| JP (1) | JP2004514424A (es) |
| KR (1) | KR20030034178A (es) |
| CN (1) | CN1246456C (es) |
| AR (1) | AR033574A1 (es) |
| AU (2) | AU2056102A (es) |
| BG (1) | BG107657A (es) |
| BR (1) | BR0114105A (es) |
| CA (1) | CA2420160A1 (es) |
| CZ (1) | CZ2003749A3 (es) |
| HU (1) | HUP0302585A3 (es) |
| IL (1) | IL154284A0 (es) |
| MX (1) | MXPA03001673A (es) |
| NO (1) | NO20031159L (es) |
| NZ (1) | NZ524527A (es) |
| PL (1) | PL365246A1 (es) |
| RU (1) | RU2294366C2 (es) |
| SK (1) | SK3642003A3 (es) |
| WO (1) | WO2002024883A2 (es) |
| ZA (1) | ZA200301244B (es) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1239032A1 (en) * | 2001-03-02 | 2002-09-11 | Société des Produits Nestlé S.A. | Lactic acid bacteria as agents for treating and preventing allergy |
| EP1319410A1 (en) * | 2001-12-11 | 2003-06-18 | Société des Produits Nestlé S.A. | Use of micro-organisms for a directed delivery of substances to specific parts of the gut |
| WO2004112773A1 (en) * | 2003-04-24 | 2004-12-29 | Shin-Jen Shiao | Pharmaceutical compositions used for immune disease treatment and improvement |
| US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| KR20070089231A (ko) * | 2004-12-14 | 2007-08-30 | 알크-아벨로 에이/에스 | 이종 단백질성 화합물을 제시하는 박테리아 세포를포함하는 약제학적 조성물 |
| WO2006097949A1 (en) * | 2005-03-16 | 2006-09-21 | Actial Farmacêutica, Lda. | Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough |
| JP4938005B2 (ja) | 2005-05-31 | 2012-05-23 | ザ・アイムス・カンパニー | ネコ科動物プロバイオティックであるラクトバシラス |
| WO2006130188A1 (en) | 2005-05-31 | 2006-12-07 | The Iams Company | Feline probiotic bifidobacteria |
| US20100233318A1 (en) * | 2006-03-31 | 2010-09-16 | Luppo Edens | Process for the hydrolysis of milk proteins |
| WO2008093303A2 (en) | 2007-02-01 | 2008-08-07 | The Iams Company | Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts |
| US9771199B2 (en) * | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| US9232813B2 (en) * | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
| AU2010207817B2 (en) * | 2009-01-27 | 2015-10-15 | Arla Foods Amba | Long shelf life milk and milk-related products, and a process and milk processing plant for their manufacture |
| BRPI1012849A2 (pt) * | 2009-05-11 | 2018-06-19 | Nestec Sa | lactobacillus johnsonii la1 ncc533 (cncm i-1225) e distúrbios imunes |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| EP2575509A1 (en) * | 2010-06-04 | 2013-04-10 | N.V. Nutricia | Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
| CA2847478A1 (en) * | 2011-09-02 | 2013-03-07 | Dh Technologies Development Pte. Ltd. | System and method for the detection of allergens |
| WO2013083140A1 (en) | 2011-12-07 | 2013-06-13 | N.V. Nutricia | Beta-lactoglobulin peptides for treating cow's milk protein allergy |
| WO2016148562A1 (en) * | 2015-03-18 | 2016-09-22 | N.V. Nutricia | Method for inducing oral tolerance via administration of beta-lactoglobulin derived peptide in combination with probiotic |
| CN105362296A (zh) * | 2015-11-27 | 2016-03-02 | 成都吉氧屋科技有限公司 | 乳酸菌洗鼻液 |
| WO2019212330A1 (en) * | 2018-04-30 | 2019-11-07 | N.V. Nutricia | Formula with a specific beta-lactoglobulin peptide |
| WO2019212329A1 (en) * | 2018-04-30 | 2019-11-07 | N.V. Nutricia | Formula with specific beta-lactoglobulin peptides |
| WO2020232451A2 (en) * | 2019-05-16 | 2020-11-19 | Trillitye PAULLIN | Method, system and apparatus for substance identification |
| CN114149486B (zh) * | 2021-05-28 | 2023-05-12 | 中国科学院大连化学物理研究所 | 一种抗菌肽mamp-01及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9302855D0 (sv) * | 1993-09-06 | 1993-09-06 | Martin Lindberg | Method and means for producing plasmaproteinase inhibitor binding proteins |
| US5817308A (en) * | 1994-02-14 | 1998-10-06 | University Of Rochester | Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance |
| AU2149495A (en) | 1995-04-11 | 1996-10-30 | Nederlandse Organisatie Voor Toegepast- Natuurwetenschappelijk Onderzoek Tno | Method for the construction of vectors for lactic acid bacte ria like lactobacillus such that the bacteria can efficientl y express, secrete and display proteins at the surface |
| FI104465B (fi) * | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
| GB9518323D0 (en) * | 1995-09-07 | 1995-11-08 | Steidler Lothar | Materials and methods relating to the attachment and display of substances on cell surfaces |
| RU2170023C2 (ru) * | 1997-12-25 | 2001-07-10 | Петров Леонид Николаевич | Штамм lactobacillus acidophilus а-91, используемый для приготовления кисломолочных продуктов, штамм lactobacillus acidophilus h-91, используемый для приготовления кисломолочных продуктов, закваска для приготовления кисломолочных продуктов и препарат, способствующий адаптации организма к неблагоприятным внешним воздействиям |
| US6100388A (en) * | 1998-03-16 | 2000-08-08 | Biogaia Biologies Ab | Lactobacilli harboring aggregation gene as a vaccine delivery vehicle |
| MY129566A (en) | 1999-01-19 | 2007-04-30 | Nestle Sa | A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance |
-
2001
- 2001-09-21 MX MXPA03001673A patent/MXPA03001673A/es not_active Application Discontinuation
- 2001-09-21 BR BR0114105-8A patent/BR0114105A/pt not_active IP Right Cessation
- 2001-09-21 RU RU2003112013/13A patent/RU2294366C2/ru not_active IP Right Cessation
- 2001-09-21 HU HU0302585A patent/HUP0302585A3/hu unknown
- 2001-09-21 KR KR10-2003-7003576A patent/KR20030034178A/ko not_active Withdrawn
- 2001-09-21 CZ CZ2003749A patent/CZ2003749A3/cs unknown
- 2001-09-21 JP JP2002529478A patent/JP2004514424A/ja not_active Withdrawn
- 2001-09-21 WO PCT/EP2001/010956 patent/WO2002024883A2/en not_active Ceased
- 2001-09-21 EP EP01985270A patent/EP1379635A2/en not_active Withdrawn
- 2001-09-21 CA CA002420160A patent/CA2420160A1/en not_active Abandoned
- 2001-09-21 AU AU2056102A patent/AU2056102A/xx active Pending
- 2001-09-21 CN CNB018162436A patent/CN1246456C/zh not_active Expired - Fee Related
- 2001-09-21 SK SK364-2003A patent/SK3642003A3/sk not_active Application Discontinuation
- 2001-09-21 PL PL01365246A patent/PL365246A1/xx not_active Application Discontinuation
- 2001-09-21 NZ NZ524527A patent/NZ524527A/en unknown
- 2001-09-21 AU AU2002220561A patent/AU2002220561B2/en not_active Ceased
- 2001-09-21 IL IL15428401A patent/IL154284A0/xx unknown
- 2001-09-21 US US10/362,249 patent/US7498162B2/en not_active Expired - Fee Related
- 2001-09-24 AR ARP010104483A patent/AR033574A1/es not_active Application Discontinuation
-
2003
- 2003-02-14 ZA ZA200301244A patent/ZA200301244B/en unknown
- 2003-03-13 NO NO20031159A patent/NO20031159L/no unknown
- 2003-03-21 BG BG107657A patent/BG107657A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ2003749A3 (cs) | 2003-06-18 |
| WO2002024883A3 (en) | 2003-11-06 |
| ZA200301244B (en) | 2004-05-14 |
| AU2002220561C1 (en) | 2002-04-02 |
| NZ524527A (en) | 2005-05-27 |
| AR033574A1 (es) | 2003-12-26 |
| NO20031159D0 (no) | 2003-03-13 |
| US7498162B2 (en) | 2009-03-03 |
| CN1246456C (zh) | 2006-03-22 |
| HUP0302585A2 (hu) | 2003-10-28 |
| AU2056102A (en) | 2002-04-02 |
| PL365246A1 (en) | 2004-12-27 |
| EP1379635A2 (en) | 2004-01-14 |
| BR0114105A (pt) | 2003-07-29 |
| BG107657A (bg) | 2003-12-31 |
| JP2004514424A (ja) | 2004-05-20 |
| AU2002220561B2 (en) | 2007-01-11 |
| CA2420160A1 (en) | 2002-03-28 |
| IL154284A0 (en) | 2003-09-17 |
| WO2002024883A2 (en) | 2002-03-28 |
| CN1479788A (zh) | 2004-03-03 |
| SK3642003A3 (en) | 2003-08-05 |
| HUP0302585A3 (en) | 2007-05-02 |
| US20040071714A1 (en) | 2004-04-15 |
| NO20031159L (no) | 2003-05-20 |
| RU2294366C2 (ru) | 2007-02-27 |
| KR20030034178A (ko) | 2003-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL365246A1 (en) | Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions | |
| AU2001254624A1 (en) | Human coagulation factor vii variants | |
| DK0749317T3 (da) | Terapeutiske anvendelser af dimerprodukter af baktericidt/permeabilitetsforøgende protein | |
| IL134830A0 (en) | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them | |
| BR0113822A (pt) | Vacina | |
| EP2364716A3 (en) | Compositions and methods for the treatment of natural killer cell related diseases | |
| TW200514847A (en) | Lactic acid bacteria having mucosal immunopotentiation effect | |
| AU3368497A (en) | Human dnase i hyperactive variants | |
| IL152659A (en) | Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer | |
| MXPA01007710A (es) | Agente de secado por congelacion que contiene paramilon, su produccion y uso. | |
| MY129150A (en) | Novel sulfamides | |
| BR0306846A (pt) | Produto substituto do sangue, composição útil como um substituto do sangue, método para fazer um produto substituto do sangue, e, método de uso de um produto substituto do sangue para fornecer oxigênio a um tecido | |
| CA2420874A1 (en) | Active ingredient combinations with insecticidal and acaricidal properties | |
| MXPA02004933A (es) | Composiciones cosmeticas conteniendo extracto de garbanzo y retinoides. | |
| MXPA04005346A (es) | Uso de microorganismos para una distribucion dirigida de sustancias a partes especificas del intestino. | |
| CA2388910A1 (en) | Antimicrobial activity of the first cationic cluster of human lactoferrin | |
| AU4011300A (en) | Compositions and methods for the treatment of immune related diseases | |
| SE9704584L (sv) | Framställning av konjugerad linolsyra | |
| IT1270618B (it) | Proteine ad attivita' antitumorale | |
| MY140724A (en) | Novel arylethene-sulfonamides | |
| AU2001267561A1 (en) | Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents | |
| AU2821200A (en) | Matrix protein compositions for grafting | |
| MXPA03004539A (es) | Luciferasas aisladas y uso de las mismas. | |
| MX9304070A (es) | Piperidilamidas, piperidilsulfonamidas y piperidilsulfoxamidas novedosas como inhibidores de la biosintesis del colesterol. | |
| PT1124577E (pt) | Utilizacao de uma proteina ompa de enterobacteria para o direccionamento especifico para as celulas apresentadoras de antigenios |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |